AUGUSTA, ME – Patients diagnosed with post-traumatic stress, Crohn’s disease, and other debilitating disorders will soon be eligible for cannabis therapy under legislation approved last week absent the Governor’s signature. Read this entire article.

[message type=”custom” width=”100%” color=”#CCCCCC” border=”#C9C9C9″ color=”#333333″] In May, researchers at the Meir Medical Center in Israel reported that inhaling cannabis reduces symptoms of Crohn’s disease compared to placebo in patients non-responsive to traditional therapies. Investigators concluded, “Our data show that 8-weeks treatment with THC-rich cannabis, but not placebo, was associated with a significant decrease of 100 points in CDAI (Crohn’s Disease and activity index) scores.”

Clinical trial data published in the May issue of the journal Molecular Psychiatry theorized that cannabinoid-based therapies would likely comprise the “next generation of evidence-based treatments for PTSD (post-traumatic stress disorder).” Read more. [/message]

Photo Credit: http://www.thedailychronic.net